Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HutP is an RNA-binding protein found in Bacillus subtilis and related species that regulates the histidine utilization (hut) operon through a transcription antitermination mechanism (UniProt P10943). It functions as a hexameric complex that requires the simultaneous binding of L-histidine and divalent metal ions, such as magnesium, to achieve its active conformation (PubMed: 12486130). Once activated, HutP binds to the leader region of the hut mRNA, specifically at three UAG-rich repeats, which prevents the formation of a rho-independent terminator structure and allows transcription to proceed into the structural genes (PubMed: 15531891). This protein is a key model for studying ligand-mediated protein-RNA interactions and the regulation of bacterial catabolic pathways. While not currently a target for FDA-approved drugs, HutP represents a class of bacterial regulatory proteins that could be targeted for the development of narrow-spectrum antimicrobials (PubMed: 18436571).
Ligand-dependent RNA binding to prevent transcription termination
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histidine utilization operon antiterminator protein HutP (HutP).